COHANCE
NIFTY500
Cohance Lifesciences Ltd.
Pharma · NSE
₹478.95
1Y—
52-week range
₹267 – ₹1,123
From 52w high
-57.4%
RSI (14)
66.9
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
94.3
Forward PE
45.9
ROE
—
Profit margin
5.6%
D/E
11.49
Dividend yield
—
Quality score
27/100
Revenue growth
77.3%
Earnings growth
-70.3%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.